Successful partnerships

Successful partnerships

The collaborative environment of the Monash Technology Precinct is underpinned by an integrated network of infrastructure, which enables our partners to push the limits of possibility.

Firstsource Solutions Limited

RP-Sanjiv Goenka Group’s Firstsource Solutions Limited are co-developing the next-generation of AI solutions that translate cutting-edge research into scalable, responsible innovations delivering impactful outcomes for business, government, and society.

Jupiter Ionics

Award-winning Monash University spin-out company Jupiter Ionics uses an electrochemical process to produce ‘Green Ammonia’ by reducing nitrogen extracted from the air and combining it with hydrogen extracted from water, with power provided by renewable electricity - a world-first and a game-changer that is set to revolutionise the global energy and agro industries.

Moderna mRNA Vaccine Production Facility

Moderna will be joining other world-leading research and technology companies in the Monash Technology Precinct, under an agreement signed with the Victorian government. Moderna will build its first mRNA production facility in the Southern Hemisphere at the Monash Technology Precinct and is expected to produce up to 100 million vaccine doses each year in Australia, including COVID-19, influenza and respiratory syncytial virus (RSV).

Monash Performing Arts Centres

The Monash Performing Arts Centres are your home for extraordinary live entertainment and experiences. A home for dreaming, storytelling, song and ceremony awaits at this safe and exciting place of community, creativity, discovery and hope, they are the The cultural heart of Melbourne’s South East Region.

Monash Precinct Network

The Monash Precinct Network is the foundation of collaboration within the Monash Technology Precinct, bringing together companies, institutions, university and government located in or considering investing in the Precinct.

Seer and Thermo Fisher Scientific

Monash University's Proteomics & Metabolomics Platform is set to revolutionise the field of proteomics and multiomics with the partnerships with Seer Inc. and Thermo Fisher Scientific; bringing cutting-edge technology to the forefront of research, enhancing the platform's capabilities and opening new avenues for scientific discoveries and translational omics research.